✦ LIBER ✦

Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

✍ Scribed by Gensicke, Henrik; Leppert, David; Yaldizli, ÃzgÃ¼r; Lindberg, Raija L.P.; Mehling, Matthias; Kappos, Ludwig; Kuhle, Jens

Book ID: 120196021
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2012
Tongue: English
Weight: 293 KB
Volume: 26
Category: Article
ISSN: 1172-7047
DOI: 10.2165/11596920-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoclonal antibody treatments for multi

Monoclonal antibody treatments for multiple sclerosis

✍ John W. Rose; John F. Foley; Noel G. Carlson 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 326 KB

Monoclonal antibody treatments for multi

Monoclonal antibody treatments for multiple sclerosis

✍ John W. Rose; John Foley; Noel Carlson 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 330 KB

Monoclonal antibodies in treatment of mu

Monoclonal antibodies in treatment of multiple sclerosis

✍ Rommer, P. S.; Dudesek, A.; Stüve, O.; Zettl, U.K. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Monoclonal antibodies in the therapy of

Monoclonal antibodies in the therapy of multiple sclerosis

✍ P. S. Rommer; O. Stüve; R. Goertsches; E. Mix; U. K. Zettl 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 184 KB

Pulsed monoclonal antibody treatment and

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

✍ Alasdair J Coles; Mark Wing; Sheila Smith; Francesca Coraddu; Sandra Greer; Crai 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 59 KB

Monoclonal antibody treatment exposes th

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

✍ Alasdair J. Coles; Mark G. Wing; Paul Molyneux; Andrea Paolillo; Charlie M. Davi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

The elective treatment of patients with multiple sclerosis, using a humanized anti-leukocyte (CD52) monoclonal antibody (Campath-1H), has illuminated mechanisms that underlie the clinical course of the disease. Twenty-seven patients were studied clinically and by magnetic resonance imaging (MRI) bef